Program Description

Total Page:16

File Type:pdf, Size:1020Kb

Program Description Department of Cardiac Surgery Program Description Quick Links Clinical Case Volumes Excellence FY2008 FY2009 FY2010 FY2011 FY2012 Page 2 The Department of Cardiac Adult 1130 1216 1172 1034 1245 • Areas of Specialty Surgery, which includes Pediatric 439 462 481 517 480 Page 3 the Division of Pediatric • Teaching & Cardiac Surgery, provides Residency comprehensive surgical Academics and Research • Outreach services for patients with In addition to studying new ways to surgically treat • Alliances cardiovascular disease. We congenital and adult heart disease, we maintain a • Infrastructure focus on providing the national presence in several national clinical trials. most innovative surgical Online procedures that are safe, • The Department of Cardiac Surgery • View a listing of all state-of-the-art and of was chosen as only one of 15 major current and pending research the highest quality. Our academic centers involved in the first NIH projects here. adult surgical outcomes observational trial for hybrid coronary • View a listing of are ranked third best in the revascularization – the combination of publications here. country according to recent coronary stenting and bypass surgery. University HealthSystem Consortium (UHC) data. Our Pediatric program is one • Vanderbilt was chosen to be part of the of only 15 centers nationwide to be certified as a Pediatric first U.S. trial of the CoreValve® trans- Heart Transplant Center of Excellence by OptumHealth catheter aortic-valve system (Medtronic, Clinical Sciences Institute. We are recognized nationally as Minneapolis, MN). a pioneer in “hybrid” coronary artery revascularization; and • Vanderbilt was the largest enrolling site our program is also renowned as a leader in congenital and for the St. Jude Medical TrifectaTM Valve. acquired valvular heart disease, minimally invasive cardiac Vanderbilt is also participating in the Post- surgical techniques and cardiac transplantation. Approval Study. By partnering with the Vanderbilt Heart and Vascular Institute, the Monroe Carell Jr. Children’s Hospital at Vanderbilt and the Vanderbilt Transplant Center, our patients benefit from experienced surgeons who collaborate Groundbreaking Achievements with specialists in all areas of cardiovascular disease to • Vanderbilt Cardiac surgery celebrates busiest determine the most appropriate care for each individual. year in history Informatics • New stent helps diabetic heart patients By fully incorporating Informatics into the Department, • Vanderbilt offers new aortic valve technique we have developed the Cardiovascular Outcomes Research • Vanderbilt performs 100th transcatheter Enterprise and and Workflow Efficiency Tools. aortic valve-replacement (TAVR) The Cardiovascular Outcomes Research Enterprise is a collaborative effort of clinicians, nurses, statisticians, • Trial tests novel treatment for heart failure epidemiologists, researchers and scientists from patients Informatics to enable academic queries of clinical • Cardiac surgeons study genetics of heart databases, comparative effectiveness evaluations, quality condition to uncover new treatments improvements and dashboards. Workflow Efficiency Tools include real-time dashboards • Pediatric cardiac tissue bank aims to solve that facilitate OR scheduling, real-time reminders heart disease mysteries and notifications and enhanced tools for electronic documentation. Areas of Specialty Acquired (Adult) Heart Disease Coronary Revascularization Program Our surgeons perform advanced techniques in coronary revas- cularization, including off-pump coronary bypass, minimally invasive coronary bypass, coronary endarterectomy and trans- myocardial laser revascularization, and multiple artery bypass grafting. Cardiac Valve Program The Vanderbilt Cardiac Valve Program unites a multidisci- plinary team of cardiologists, radiologists, anesthesiologists and surgeons trained in diagnosing and treating all disorders of cardiac valves. Guided by diagnostic techniques, includ- ing cardiac MRI and trans-esophageal echocardiography, TAVR Program our surgeons perform all types of aortic, mitral, pulmonary Vanderbilt began using trans-catheter aortic valves and tricuspid valve operations including: mitral valve repair, (TAVR) in adult patients in July 2011 when it embarked mitral valve replacement with biological or mechanical valve on a clinical trial of Medtronic’s CoreValve. Vanderbilt is prostheses, aortic valve replacement using stented or stentless one of a few medical centers in the country to offer both tissue valves or mechanical valve prostheses, tricuspid valve the CoreValve and the SAPIEN valve, and we are the repair or replacement, aortic root replacement with tissue most experienced hospital in Tennessee at replacing heart or mechanical valves, valve-sparing aortic root reconstruc- valves using TAVR. tions and pulmonary autograft switch operation in younger patients. In addition, Vanderbilt Heart’s hybrid OR allows thoracic aorta, including acute aortic dissections, aortic aneu- minimally invasive valve surgery to be performed in patients rysms, and Marfan’s syndrome. Also, as on the of the leading with concomitant coronary artery disease. This allows percu- trauma centers in the Southeast, we perform surgical repair of taneous approaches to coronary disease to be combined with traumatic aortic rupture. minimally invasive techniques for valve replacement surgery. Atrial Fibrillation/Arrhythmia Repair Program Heart Failure and VAD/Transplant Program Vanderbilt Heart’s hybrid OR allows us to combine catheter- Vanderbilt Heart has extensive experience treating patients based procedures with minimally invasive surgical approaches with heart failure and advanced cardiomyopathies. Our team to achieve optimal results. Our multidisciplinary team of includes cardiac and transplant surgeons, specially trained cardiologists and surgeons provides comprehensive treatment and certified cardiologists, nurse practitioners, social workers, of atrial fibrillation, including optimal medical management, dieticians, psychologists, pharmacists and infectious disease catheter-based ablation procedures, and minimally invasive doctors. Many studies have shown that this multidisciplinary surgical ablation. approach makes for better outcomes and improved quality of life for our patients. This team gives heart failure patients op- Congenital (Pediatric) Heart Disease tions including: optimal medical management, investigation- al drugs, bi-ventricular pacing, conventional (non-transplant, Adult Congenital Cardiac Surgery non-assist device) surgical procedures (ventricular restoration As patients who have previously had congenital cardiac sur- procedures), mechanical assist devices as a bridge to transplan- gery reach adulthood, a significant number will require surgi- tation and heart transplantation. Recently, Vanderbilt Heart cal or percutaneous repair of associated congenital lesions. As received Advanced Certification in Ventricular Assist Devices one of the leading pediatric cardiac surgery programs in the from The Joint Commission, allowing us to provide Destina- nation, Vanderbilt Heart provides state-of-the-art surgical tion Therapy for patients for whom transplantation is not an repair of these lesions, frequently with newer non-operative, option. percutaneous approaches. Our surgical and interventional teams work together to recommend the more appropriate Aortic Surgery Program treatment. In our “Hybrid OR,” we can combine traditional The Vanderbilt Aortic Surgery Program offers diagnosis and surgical and percutaneous approaches when appropriate. state-of-the-art treatment of aortic root, ascending, arch and • Closure of atrial or ventricular septal defects descending thoracic aortic pathology, including aortic aneu- • Norwood procedure rysms and dissections. By using a multidisciplinary approach • Fontan procedure involving cardiac surgeons, cardiologists, radiologists and • Hybrid surgical strategies vascular surgeons, we are able to treat all conditions of the • Robotic, minimally invasive procedures Teaching and Residency We are committed to training the next generation of cardiac surgeons through an ACGME-approved cardio- thoracic (CT) training program. In the future, we envision an Integrated Six- Year CT Residency Program, a paradigm which has been successful at a number of academic centers through the U.S. This six-year CT program ideally would incorporate General Surgery, Cardiology, Vascular Surgery, Thoracic Surgery, and Cardiac Surgery. Very shortly, the Department of Thoracic Surgery and the Department of Cardiac Surgery will apply for ACGME approval of this six-year integrated program format. We believe this format will attract an elite group of medical students who could complete the program in six years instead of the traditional seven or eight. Outreach Infrastructure Outreach is an integral component of Cardiac Surgery’s Providers and Partners growth. Our dedicated physician liaison works with our physicians to strategically ensure continued market • Cardiologists development by: • Cardiac Anesthesiologists • Establishing and maintaining a network of strong (all perform Intra-op TEE) relationships with physicians throughout Tennessee • Perfusionists and adjacent states, • Intensivists • Access • Orchestrating and implementing educational programs for physicians in the community, and Operating Rooms • Collaborating with new physicians to assist in • 3 Traditional Cardiac ORs + 1 Cardiac developing and executing a marketing plan to build Hybrid Suite
Recommended publications
  • Early Diastolic Clicks After the Fontan Procedure for Double
    304 Br Heart J 1990;63:304-7 Early diastolic clicks after the Fontan procedure for double inlet left ventricle: anatomical and physiological correlates Br Heart J: first published as 10.1136/hrt.63.5.304 on 1 May 1990. Downloaded from Andrew N Redlngton, Kit-Yee Chan, Julene S Carvalho, Elliot A Shinebourne Abstract inlet ventricle with two atrioventricular M mode echocardiograms and simultan- valves. All had previously undergone a Fontan eous phonocardiograms were recorded type procedure with direct atriopulmonary in four patients with early diastolic anastomosis. In two patients a valved clicks on auscultation. All had double homograft was interposed between the right inlet left ventricle and had undergone atrium and pulmonary artery. Each patient the Fontan procedure with closure of the had the right atrioventricular valve closed by right atrioventricular valve orifice by an either a single or double layer of Dacron cloth artifical patch. The phonocardiogram sewn into the floor of the right atrium. The confirmed a high frequency sound main pulmonary artery was tied off in all. occurring 60-90 ms after aortic valve Cross sectional, M mode, and pulsed wave closure and coinciding with the time of Doppler echocardiograms with simultaneous maximal excursion of the atrioven- electrocardiogram and phonocardiogram were tricular valve patch towards the ven- recorded on a Hewlett-Packard 77020A tricular mass. One patient had coexist- ultrasound system. The phonocardiogram was ing congenital complete heart block. recorded over the point on the chest where the The M mode echocardiogram showed diastolic click was best heart on auscultation, i'reversed") motion of the patch towards usually in the fourth left intercostal space the right atrium during atrial contrac- close to the sternum.
    [Show full text]
  • Modified Fontan Procedure: Extracardiac Conduit
    Normal Heart © 2012 The Children’s Heart Clinic NOTES: Children’s Heart Clinic, P.A., 2530 Chicago Avenue S, Ste 500, Minneapolis, MN 55404 West Metro: 612-813-8800 * East Metro: 651-220-8800 * Toll Free: 1-800-938-0301 * Fax: 612-813-8825 Children’s Minnesota, 2525 Chicago Avenue S, Minneapolis, MN 55404 West Metro: 612-813-6000 * East Metro: 651-220-6000 © 2012 The Children’s Heart Clinic Reviewed March 2019 Modified Fontan Procedure: Extracardiac Conduit The Fontan procedure is usually the third procedure done in a series of surgeries to complete palliation of single ventricle patients. This procedure separates the “blue,” deoxygenated blood from the “red,” oxygenated blood circuit. Once the Fontan is done, deoxygenated blood drains passively to the pulmonary arteries, then to the lungs. Blood receives oxygen from the lungs and returns to the heart, where it is actively pumped out to the body. This procedure is usually done between 2-4 years of age. During surgery, the chest is opened through the previous incision, using a median sternotomy. The operation may or may not involve the use of cardiopulmonary bypass (heart-lung machine), depending on the surgical plan. A Gore-tex® tube graft (Gore) is cut to the appropriate length. An incision is made on the pulmonary artery near the area of the existing bidirectional Glenn shunt (cavopulmonary anastomosis) and the tube graft is sutured to the artery. Once that is complete, the inferior vena cava is divided from the atrium. The lower end of the Gore-tex® tube graft (Gore) is then sutured to the inferior vena cava.
    [Show full text]
  • Management of Acute Limb Ischemia in the Emergency Department
    edicine: O M p y e c n n A e c g c r e e s Diaconu, Emerg Med (Los Angel) 2015, 5:6 s m E Emergency Medicine: Open Access DOI: 10.4172/2165-7548.1000E139 ISSN: 2165-7548 Editorial Open Access Management of Acute Limb Ischemia in the Emergency Department Camelia C Diaconu* University of Medicine and Pharmacy “Carol Davila”, Clinical Emergency Hospital of Bucharest, Romania *Corresponding author:Camelia C Diaconu, MD, Ph.D, University of Medicine and Pharmacy “Carol Davila”, Clinical Emergency Hospital of Bucharest, Romania, E- mail: [email protected] Received date: October 19, 2015; Accepted date: October 23, 2015; Published date: October 30, 2015 Copyright: © 2015 Diaconu CC. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Editorial lab, under local anesthesia, in patients with Rutherford IIa ischemia. Patients with Rutherford IIb ischemia need immediate surgical Acute limb ischemia (ALI) is an emergency condition caused by the revascularization. The endovascular interventions have the best results sudden occlusion of an artery. The tissue perfusion is compromised in the femuro-popliteal segment and in the thrombosed vascular grafts and the viability of the limb is threatened. The etiology of acute limb or thrombosed stents (compared to thrombosed native arteries). ischemia may be acute thrombosis, an embolic event or trauma. Catheter-directed thrombolysis is a technique that uses thrombolytic Sometimes, it appears when thrombosis occurs on a pre-existing agents (plasminogen activators).
    [Show full text]
  • The Physiology of the Fontan Circulation ⁎ Andrew Redington
    Progress in Pediatric Cardiology 22 (2006) 179–186 www.elsevier.com/locate/ppedcard The physiology of the Fontan circulation ⁎ Andrew Redington Division of Cardiology, The Department of Pediatrics, The Hospital for Sick Children, University of Toronto School of Medicine, Toronto, Ontario, Canada Available online 8 September 2006 Abstract The Fontan circulation, no matter which of its various iterations, is abnormal in virtually every aspect of its performance. Some of these abnormalities are primarily the result of the procedure itself, and others are secondary to the fundamental disturbances of circulatory performance imposed by the ‘single’ ventricle circulation. The physiology of ventricular, systemic arterial and venopulmonary function will be described in this review. © 2006 Elsevier Ireland Ltd. All rights reserved. Keywords: palliation; Fontan circulation; Cavopulmonary anastomosis; Antriopulmonary anastomosis 1. Introduction has the profound consequences for the systemic ventricle that will discussed below. At the same time as the bidirectional In this personal overview, I will discuss the physiology of the cavopulmonary anastomosis was becoming almost uniformly Fontan circulation. Bob Freedom's contribution to our under- adopted, there was abandonment of the ‘classical’ atriopulmon- standing of complex congenital heart disease has meant that ary anastomosis, in favour of the total cavopulmonary con- many more of these patients are surviving with this physiology nection (TCPC). The ‘lateral wall’ TCPC, popularised by Marc than could have been contemplated 30 years ago. Nonetheless, deLeval [1], was shown experimentally and clinically to be they represent a very difficult group of patients and we continue haemodynamically more efficient [1,2] and set the scene for the to learn more about this unique circulation.
    [Show full text]
  • Percutaneous Revascularization of the Lower Extremities in Adults Table of Contents Related Coverage Resources
    Medical Coverage Policy Effective Date ............................................. 3/15/2021 Next Review Date ....................................... 3/15/2022 Coverage Policy Number .................................. 0537 Percutaneous Revascularization of the Lower Extremities in Adults Table of Contents Related Coverage Resources Overview.............................................................. 1 Venous Angioplasty and/or Stent Placement in Adults Coverage Policy .................................................. 1 General Background ........................................... 2 Medicare Coverage Determinations .................. 17 Coding/Billing Information ................................. 17 References ........................................................ 19 INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans upon which these Coverage
    [Show full text]
  • Choosing the Correct Therapeutic Option for Acute Limb Ischemia
    REVIEW Choosing the correct therapeutic option for acute limb ischemia Acute limb ischemia (ALI) occurs due to abrupt interruption of arterial flow to an extremity, which may lead to loss of limb or life. ALI is typically caused by either a thrombotic or embolic arterial occlusion. Management strategies, which may not be mutually exclusive, include anticoagulation and observation, catheter-directed thrombolysis and/or surgical thrombectomy. The therapeutic choice depends on the patient functional status, severity of ischemia and time required for treatment. A logical approach to the evaluation and management of patients with ALI is presented in this article. 1 KEYWORDS: acute limb ischemia n arterial embolus n arterial thrombosis Jeffrey A Goldstein & n catheter‑directed thrombolysis n limb salvage n peripheral arterial disease Gregory Mishkel†1 n thrombectomy n thrombolysis 1Prairie Cardiovascular Consultants, PO Box 19420, Springfield, IL 62794-9420, USA Present day cardiology has evolved from exclu- disease (PAD) may eventually develop ALI †Author for correspondence: sively directing the cardiologic health of patients, [3]. The majority of ALI cases (85%) are due Tel.: +1 217 788 0708 Fax: +1 217 788 8794 to additionally managing their vascular health. to in situ thrombosis, with the remaining 15% [email protected] Increasingly, both general and particularly inter- of cases due to embolic arterial occlusion. The ventional cardiologists are called upon to man- vast majority of emboli, upwards of 90%, are age the care of the patients in their practice when cardiac in etiology [6] and are usually due to they present with acute vascular emergencies. either atrial fibrillation or acute myocardial inf- Unfortunately, subsequent to their subspecialty arction.
    [Show full text]
  • Peripheral Angioplasty – Revascularization: Femoral/Popliteal Artery(S)
    Surgical Services: Peripheral Angioplasty – Revascularization: Femoral/Popliteal Artery(s) POLICY INITIATED: 06/30/2019 MOST RECENT REVIEW: 06/30/2019 POLICY # HH-5675 Overview Statement The purpose of these clinical guidelines is to assist healthcare professionals in selecting the medical service that may be appropriate and supported by evidence to improve patient outcomes. These clinical guidelines neither preempt clinical judgment of trained professionals nor advise anyone on how to practice medicine. The healthcare professionals are responsible for all clinical decisions based on their assessment. These clinical guidelines do not provide authorization, certification, explanation of benefits, or guarantee of payment, nor do they substitute for, or constitute, medical advice. Federal and State law, as well as member benefit contract language, including definitions and specific contract provisions/exclusions, take precedence over clinical guidelines and must be considered first when determining eligibility for coverage. All final determinations on coverage and payment are the responsibility of the health plan. Nothing contained within this document can be interpreted to mean otherwise. Medical information is constantly evolving, and HealthHelp reserves the right to review and update these clinical guidelines periodically. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, mechanical, photocopying, or otherwise, without permission from HealthHelp. All trademarks,
    [Show full text]
  • Arterial Switch Operation Surgery Surgical Solutions to Complex Problems
    Pediatric Cardiovascular Arterial Switch Operation Surgery Surgical Solutions to Complex Problems Tom R. Karl, MS, MD The arterial switch operation is appropriate treatment for most forms of transposition of Andrew Cochrane, FRACS the great arteries. In this review we analyze indications, techniques, and outcome for Christian P.R. Brizard, MD various subsets of patients with transposition of the great arteries, including those with an intact septum beyond 21 days of age, intramural coronary arteries, aortic arch ob- struction, the Taussig-Bing anomaly, discordant (corrected) transposition, transposition of the great arteries with left ventricular outflow tract obstruction, and univentricular hearts with transposition of the great arteries and subaortic stenosis. (Tex Heart Inst J 1997;24:322-33) T ransposition of the great arteries (TGA) is a prototypical lesion for pediat- ric cardiac surgeons, a lethal malformation that can often be converted (with a single operation) to a nearly normal heart. The arterial switch operation (ASO) has evolved to become the treatment of choice for most forms of TGA, and success with this operation has become a standard by which pediatric cardiac surgical units are judged. This is appropriate, because without expertise in neonatal anesthetic management, perfusion, intensive care, cardiology, and surgery, consistently good results are impossible to achieve. Surgical Anatomy of TGA In the broad sense, the term "TGA" describes any heart with a discordant ven- triculoatrial (VA) connection (aorta from right ventricle, pulmonary artery from left ventricle). The anatomic diagnosis is further defined by the intracardiac fea- tures. Most frequently, TGA is used to describe the solitus/concordant/discordant heart.
    [Show full text]
  • Norwood/Batista Operation for a Newborn with Dilated Myopathy of the Left Ventricle
    612 Brief communications The Journal of Thoracic and Cardiovascular Surgery September 2000 NORWOOD/BATISTA OPERATION FOR A NEWBORN WITH DILATED MYOPATHY OF THE LEFT VENTRICLE Richard D. Mainwaring, MD, Regina M. Healy, BS, John D. Murphy, MD, and William I. Norwood, MD, PhD, Wilmington, Del Partial left ventriculectomy for dilated cardiomyopathy was contractile function. The variable results that have been first reported by Batista and associates1 in 1996. The rationale reported in the adult literature may reflect patient selection for this procedure is the increase in left ventricular cavity size according to the reversibility or recoverability of the underly- in the absence of compensatory left ventricular wall thickness ing disease process. that is observed in dilated cardiomyopathy. This combination Despite the substantial worldwide experience with the of factors results in an increase in wall stress per unit muscle Batista procedure in adult patients, there is limited experience mass, as predicted by the LaPlace equation. As wall stress with this procedure in children. The current case report increases, mechanical load eventually becomes nonsustain- describes the treatment of a patient in whom the diagnosis of able and contributes to further dilation of the ventricle. Partial dilated cardiomyopathy was made in utero. left ventriculectomy has been advocated as a method of Clinical summary. A female infant was recognized in restoring the balance between cavity size and wall thickness. utero as having a dilated, poorly functioning left ventricle. Fundamental to this concept is the assumption that the left Labor was induced at 36 weeks’ gestation, and she was deliv- ventricular muscle is intrinsically normal or has recoverable ered by normal, spontaneous, vaginal delivery.
    [Show full text]
  • Clinical Value of Pelvic and Penile Magnetic Resonance Angiography in Preoperative Evaluation of Penile Revascularization
    International Journal of Impotence Research (1999) 11, 83±86 ß 1999 Stockton Press All rights reserved 0955-9930/99 $12.00 http://www.stockton-press.co.uk/ijir Clinical value of pelvic and penile magnetic resonance angiography in preoperative evaluation of penile revascularization H John*1, GM Kacl2, K Lehmann1, JF Debatin2 and D Hauri1 1Department of Urology, University Hospital Zurich, Switzerland and 2Department of Radiology, University Hospital Zurich, Switzerland Penile angiography is invasive, costly and requires postinterventional surveillance. The aim of this pilot study was to determine whether three dimensional magnetic resonance (3D-MR)- angiography may replace conventional penile angiography in preoperative planning of penile revascularization. Twelve patients with a mean age of 39 (21 ± 59) y were evaluated. All patients underwent evaluation with intracavernous pharmacotesting, color Doppler sonography (CDS), digital subtraction angiography (DSA) and pelvic MR-angiography with gadolinium diethylene- triaminepentaacetic acid (Gd-Dota) 0.2 ± 0.3 mmol=kg body weight. MR-angiography demonstrated the anatomy of the internal iliac arteries in 9 out of 12 patients. Intrapenile vessels were visible in 7 out of 12 patients. In comparison DSA provided complete visualization of all pelvic and penile vessels. Relevant arterial obstruction was found in 10 out of 12 patients. CDS revealed a mean maximal arterial ¯ow of 27 (22 ± 40) cm=s and showed in accordance to angiography arterial insuf®ency in 10 out of 12 cases. Indication for revascularization could have been based on MR- angiography alone in only one patient. Therefore, selective penile angiography remains the `gold standard' for preoperative planning of revascularization procedures.
    [Show full text]
  • The Clinical Spectrum of Fontan-Associated Liver Disease: Results from a Prospective Multimodality Screening Cohort
    Edinburgh Research Explorer The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort Citation for published version: Munsterman, ID, Duijnhouwer, AL, Kendall, TJ, Bronkhorst, CM, Ronot, M, van Wettere, M, van Dijk, APJ, Drenth, JPH & Tjwa, ETTL 2019, 'The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort', European Heart Journal, vol. 40, no. 13, pp. 1057–1068. https://doi.org/10.1093/eurheartj/ehy620 Digital Object Identifier (DOI): 10.1093/eurheartj/ehy620 Link: Link to publication record in Edinburgh Research Explorer Document Version: Peer reviewed version Published In: European Heart Journal General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 25. Sep. 2021 Title: The clinical spectrum of Fontan-Associated Liver Disease: results from a prospective multimodality screening cohort. Authors: I.D. Munsterman1, A.L. Duijnhouwer2, T.J. Kendall3, C.M. Bronkhorst4, M. Ronot5, M. van Wettere5, A.P.J. van Dijk2, J.P.H. Drenth1, E.T.T.L. Tjwa1 On behalf of the Nijmegen Fontan Initiative (A.P.J.
    [Show full text]
  • Management of Patients Undergoing Coronary Artery Revascularization
    ACCF/AHA Pocket Guideline Management of Patients Undergoing Coronary Artery Revascularization November 2011 Adapted from the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons) © 2011 by the American College of Cardiology Foundation and the American Heart Association, Inc. The following material was adapted from the 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention. J Am Coll Cardiol 2011; doi: 10.1016/j.jacc.2011.08.007; and the 2011 ACCF/ AHA guideline for coronary artery bypass graft surgery. J Am Coll Cardiol 2011; doi: 10.1016/j.jacc.2011.08.009. This pocket guideline is available on the World Wide Web sites of the American College of Cardiology (www.cardiosource.org) and the American Heart Association (my.americanheart.org). For copies of this document, please contact Elsevier Inc. Reprint Department, e-mail: [email protected]; phone: 212-633-3813; fax: 212-633-3820. Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Please contact Elsevier’s permission department at [email protected]. Contents 1. Introduction .............................................................................................
    [Show full text]